Unaudited Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2022	Dec. 31, 2021	[1]
CURRENT ASSETS
Cash and cash equivalents	$ 222,933,723	$ 262,311,670
Short-term investments	16,122,519	5,423,612
Accounts receivable, net	292,413,491	249,794,906
Inventories	418,286,161	316,267,442
Prepaid expenses and other	39,567,381	39,178,119
Total current assets	989,323,275	872,975,749
PLANT AND EQUIPMENT—NET	526,680,787	464,121,676
OTHER ASSETS
Goodwill	313,851,944	313,960,209
Long-term investments	154,429,190	207,693,147
Equity method investments	39,680,791	0
Intangible assets, net	224,185,910	239,189,627
Patents and other assets, net	63,171,166	33,450,758
Total other assets	795,319,001	794,293,741
Total assets	2,311,323,063	2,131,391,166
CURRENT LIABILITIES
Accounts payable	171,436,605	98,342,928
Accrued liabilities	93,728,038	83,313,172
Total current liabilities	265,164,643	181,656,100
OTHER NON-CURRENT LIABILITIES	12,112,756	11,746,599
Total liabilities	277,277,399	193,402,699
SHAREHOLDERS’ INVESTMENT
Common stock	14,075,843	14,186,450
Additional paid-in capital	908,622,409	879,413,385
Retained earnings	1,108,061,455	1,042,461,388
Accumulated other comprehensive (loss) income	3,285,957	1,927,244
Total shareholders’ investment	2,034,045,664	1,937,988,467
Total liabilities and shareholders’ investment	$ 2,311,323,063	$ 2,131,391,166

[1] The condensed consolidated balance sheet at December 31, 2021 has been derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.